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Cross-presentation of endocytosed antigen as peptide/class Imajor histocompatibility com-
plex complexes plays a central role in the elicitation of CD8+ T cell clones that mediate
anti-viral and anti-tumor immune responses.While it has been clear that there are speciﬁc
subsets of professional antigen presenting cells capable of antigen cross-presentation,
identiﬁcation of mechanisms involved is still ongoing. Especially amongst dendritic cells
(DC), there are specialized subsets that are highly proﬁcient at antigen cross-presentation.
We here present a focused survey on the cell biological processes in the endosomal
pathway that support antigen cross-presentation.This review highlights DC-intrinsic mech-
anisms that facilitate the cross-presentation of endocytosed antigen, including receptor-
mediated uptake, maturation-induced endosomal sorting of membrane proteins, dynamic
remodeling of endosomal structures and cell surface-directed endosomal trafﬁcking. We
will concludewith the description of pathogen-induced deviation of endosomal processing,
and discuss how immune evasion strategies pertaining endosomal trafﬁckingmay preclude
antigen cross-presentation.
Keywords: cross-presentation, endosomal recycling compartment, Rab GTPase, microtubule-organizing center,
endosomal remodeling
INTRODUCTION
Major histocompatibility complex (MHC) restriction of T lym-
phocytes was ﬁrst reported by Doherty and Zinkernagel (1975).
They provided experimental proof that T cells can only respond
to peptide antigens when they are presented in complex with
host-derived MHC molecules, existing in a class I and class II
variant. CD8+ T cells can recognize peptide/class I MHC com-
plexes, whereas CD4+ T cells can respond to peptide/class IIMHC
complexes. Soon thereafter, Bevan (1976) showed that the func-
tional dichotomy of endogenous antigen presentation on class I
MHC and exogenous antigen on class II MHC is not absolute.
He demonstrated that minor histocompatibility antigens from
transplanted cells (e.g., exogenous antigen) could prime cyto-
toxic CD8+ T cells in a host class I MHC-restricted manner and
named this process cross-priming. More recent work showed that
injected naive antigen-speciﬁc CD8+ T cells accumulate in the
lymph nodes that drain tissues expressing a membrane-bound
self-antigen in a class IMHC-dependentmanner. CD8+ Tcells can
thus survey processed self-antigen delivered from non-lymphoid
tissues,without leaving lymphoidorgans (Kurts et al.,1996). In fol-
lowing years, the capability to present exogenous antigens via class
IMHCwas shown tobe relevant fornumerous cell-associated anti-
gens in various settings, including viral, self, and tumor-associated
antigens (Heath and Carbone, 2001). Antigen presentation that
results in CD8+ T cell activation is now named cross-priming
(Bevan, 1976), whereas T cell deletion or induction of anergy is
called cross-tolerance (Albert et al., 2001; Bonifaz et al., 2002). Col-
lectively the presentation of exogenous cell-associated antigens via
class IMHCmolecules toCD8+ Tcells is called cross-presentation.
Under homeostatic conditions, cross-presentation of self-
antigens harbors the risk of autoreactivity and is therefore strictly
controlled. Under these circumstances, antigen cross-presentation
is mostly conﬁned to a speciﬁc subset of dendritic cells (DC),
notably CD8α+ DC in mice (den Haan et al., 2000) and CD141+
DC in human (Bachem et al., 2010; Crozat et al., 2010; Jong-
bloed et al., 2010; Poulin et al., 2010). CD8α+ DEC205+ mouse
DC not only excel in antigen cross-presentation, but are also
specialized in the uptake of dying cells (Dudziak et al., 2007).
Receptor-based antigen capture and cross-presentationwas shown
using a DEC205 antibody to which protein antigen was chemi-
cally coupled (Bonifaz et al., 2002; Bozzacco et al., 2007). Anti-
gen internalized via DEC205 targeting results in the continuous,
steady state capture and processing of antigen into peptide/class
I MHC complexes in a manner that results in tolerogenic CD8+
T cell responses (Bonifaz et al., 2002). Besides DC, macrophages
(Kovacsovics-Bankowski et al., 1993) and liver sinusoidal endothe-
lial cells (Limmer et al., 2000) can also cross-present antigens in
the steady state. In contrast, more cell types can cross-present
antigen during inﬂammation. Mouse DC (Jung et al., 2002),
macrophages (Kovacsovics-Bankowski et al., 1993), neutrophils
(Beauvillain et al., 2007) and under speciﬁc conditions even B
cells (Heit et al., 2004), have been demonstrated to cross-present
antigen in vivo. Additionally, cell types that can cross-present anti-
gen in vitro include basophils (Kim et al., 2009),γδT cells (Brandes
et al., 2009), mast cells (Stelekati et al., 2009), and endothelial cells
(Bagai et al., 2005).
Although multiple cells can be involved in cross-priming
in vivo, DC are especially important for this process, as shown
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by abrogated CD8+ T cell priming after depletion of CD11c+ cells
(predominantly DC) inmice (Jung et al., 2002). Hence, this review
focusesmainly onDC, formost cell-intrinsicmechanisms involved
in cross-presentation of endocytosed antigen are described in this
cell type.
In the last 15 years, at least 50 DC vaccination-based trials,
aimed in part at harnessing effective CD8+ T cell responses were
performed with overall minimal success (reviewed in Rosenberg
et al., 2004). This review aims at providing insight in molecular
mechanisms that are pivotal to cross-presentation.
ANTIGEN PROCESSING COMPARTMENT FOR
CROSS-PRESENTATION
Antigen recognition can trigger receptor-mediated endocytosis
and can bring forth the ability of cells to cross-present the
receptor-bound antigen (Sancho et al., 2009; Bachem et al., 2010;
Jongbloed et al., 2010). In contrast to complement-opsonized anti-
gen, immunoglobulin (Ig)-opsonized antigens are delivered in an
endosomal compartment that favors cross-presentation bymurine
DC (Kim et al., 2008). Because Ig-opsonized antigen is predom-
inantly endocytosed via Fc receptor and complement-opsonized
antigen via complement receptor, this study indicates that antigen
recognition dictates antigen delivery in distinct endosomal com-
partments. Ultimately, this may favor either the class I or class II
MHC presentation pathway (reviewed in Flinsenberg et al., 2011).
Aside from antigen recognition, antigen size plays a role in its
handling by phagocytes: particulate antigens that are larger than
roughly 0.5μm are internalized by phagocytosis, whereas smaller
antigens are brought in by pinocytosis (Pratten and Lloyd, 1986;
Mant et al., 2012). Onemajor route of antigen internalization that
yields cross-presentation seems to be phagocytosis, as particulate
antigens are often more efﬁciently targeted for cross-presentation
in comparison to their soluble counterparts (Graham et al., 2010).
Thus, DC internalize antigens via distinct routes that are dictated
by the structure of the antigen (i.e., particulate or soluble, size)
and possible involvement of a recognizing endocytic receptor.
Receptor-mediated endocytosis is considered to be a highly
efﬁcient process that permits the selective retrieval of macromol-
ecules present in the extracellular ﬂuid (Brown et al., 1976). Such
uptake depends on structural proteins that mediate the formation
of lipid vacuoles, e.g., clathrin or caveolin (Mayor and Pagano,
2007). Within minutes of internalization from the plasma mem-
brane into the endosomal pathway, antigen is located in vesicular
compartments named early endosomes/phagosomes, character-
ized by a near neutral pH (pH 7.5; Savina et al., 2006) and presence
of the small GTPase Rab5 (Simonsen et al., 1998). Endosomal
maturation causes the fusion of early endosomes (EE) with late
compartments, accompanied by transition of Rab5 expression to
Rab7-positivity. The endosomal compartment is now renamed
to late endosomes (LE) with their hallmark of a lowered pH
of the endosomal lumen (pH 5.5). Further maturation of the
LE leads to fusion with lysosomes in which the acidic environ-
ment (pH 4.7) and lysosomal proteases and hydrolases with low
pH optima can mediate full degradation of luminal content (i.e.,
internalized antigen, but also cellular components for turnover).
Especially DC harbor cellular mechanisms that prevent the rapid
maturation-induced acidiﬁcation of endosomal compartments,
thereby allowing protein antigen fragments to remain intact for
a prolonged time (as proteolytic activity by pH-sensitive proteases
is restrained). Thereby,DC can cross-present antigen-derived pep-
tides more efﬁciently than other phagocytes (Trombetta et al.,
2003; Savina et al., 2006). Micro-organisms exploit these mech-
anisms to prevent their display as peptide/class I MHC complexes
as immune evasion strategies (i.e., Mycobacteria and Salmonella;
Jantsch et al., 2011; Johansen et al., 2011), as will be discussed in
paragraph 6.
Peptides of 8–10 amino acids in length ﬁt within the antigen-
binding groove of class I MHC molecules, leading to a stable
formation of peptide/class I MHC complexes (Urban et al., 1994;
Rammensee, 1995). The proteasome is the foremost contributor
to cleaved peptides for the classical class IMHCpresentation path-
way. Therefore its role in cross-presentation was assessed. The use
of proteasome-selective inhibitors clariﬁed the existence of both
proteasome-dependent (Kovacsovics-Bankowski and Rock, 1995)
and independent antigen processing (Shen et al., 2004; Saveanu
et al., 2009) in distinct cross-presentation model systems. To date,
two main routes leading to cross-presentation have broad experi-
mental support: the cytosolic and vacuolar pathway. The cytosolic
pathway proposes that endocytosed antigen is transported into
the cytosol for proteasome/cytosolic peptidase-mediated degrada-
tion, whereas the vacuolar pathway relies on proteases for antigen
processing within endosomes.
The cytosolic pathway model is supported by phagosome-
to-cytosol translocation of OVA-beads (Kovacsovics-Bankowski
and Rock, 1995), OVA-IgG and HRP-IgG immune complexes in
murine cells (Rodriguez et al., 1999). Lin et al. (2008) demon-
strated that cross-presentation competent CD8α+ and not the
incapable CD8α− DC were sensitive for exogenously added
cytochrome-c (cytochrome-c induces apoptosis when cytoso-
lic concentrations are elevated). Antigen translocation from
phagosome-to-cytosol involves processes that are antigen-speciﬁc,
have antigen size-restrictions, may involve the reduction and
unfolding of protein antigen and are Sec61 complex mediated
(Rodriguez et al., 1999; Ackerman et al., 2006; Singh and Cress-
well, 2010). In addition, cytosolic transfer of apoptotic peptides
by neighboring cells and interacting dendritic cells can occur via
gap-junctions into the cross-presenting cell (Pang et al., 2009).
The processing of antigen that is translocated into the cytosol
involves the proteasome, as well as amino- and carboxy-terminal
peptidases (Levy et al., 2002; Shen et al., 2011). The transporter
associated with antigen processing (TAP) translocates the pep-
tides into the endoplasmic reticulum (ER) which thereby enter
the conventional class I MHC pathway (Ackerman et al., 2005),
or back into the phagosomal pathway in an MyD88-dependent
manner (Ackerman et al., 2003; Houde et al., 2003; Burgdorf
et al., 2008). All necessary components to enable peptide trim-
ming, loading, and translocation appear present and functional
in early phagosomes (Houde et al., 2003; Ackerman et al., 2005).
It was proposed that phagosome–ER fusion occurs to deliver the
necessary components to the phagosome (Guermonprez et al.,
2003). It now appears that rather than complete phagosome–ER
fusion, which was disputed (Touret et al., 2005), only selective
ER-derived components are delivered to phagosomes (Burgdorf
et al., 2008; Cebrian et al., 2011). The SNARE Sec22b is shown to
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recruit ER-resident proteins to phagosomes that are necessary for
phagosome-to-cytosol translocation (Cebrian et al., 2011).
Several groups demonstrated that peptide generation for cross-
presentation may occur independent of the proteasome (Shen
et al., 2004), while requiring endosomal acidiﬁcation (Gromme
et al., 1999; Di Pucchio et al., 2008). The proposed vacuolar path-
way does not require phagosome-to-cytosol translocation, but
relies on endosomal proteases for generation of antigenic peptides
(Gromme et al., 1999; Di Pucchio et al., 2008). Shen et al. showed
that cell-associatedOVAcanbedegradedbyboth cathepsin S in the
endosomal pathway or the cytosolic proteasome within one pop-
ulation of DC. This indicates that the proteasome-independent
vacuolar pathway may co-exist with the cytosolic pathways. This
possibility is supported by reports demonstrating that plasmacy-
toid DC cross-present in both proteasome-dependent and inde-
pendent pathways (Hoeffel et al., 2007; Di Pucchio et al., 2008).
In summary, antigen processing for cross-presentation depends
on distinct proteolytic enzymes and may occur in the endosomal
compartment as well as the cytosol.
These studies strengthen the concept that both antigen recogni-
tion and its physical characteristics affect antigen sorting into the
given processing pathways, thereby inﬂuencing antigen presenta-
tion. Immunization studies showed that appropriate endosomal
sorting is essential for efﬁcient cross-presentation. Immunization
with bead-coupled OVA caused CD8+ T cell responses and prolif-
eration in an Fcγ receptor and DAP12-dependent manner. Cross-
presentation of solubleOVAwas independent of Fcγ receptors and
DAP12 (Graham et al., 2007).
CLASS I MHC IN THE ENDOSOMAL COMPARTMENT
Early studies showed that TAP-dependent cross-presentation is
sensitive to Brefeldin A through its ability to block ER-to-Golgi
transport. These data fueled the initial proposal that peptide load-
ing occurs in the ER (Kovacsovics-Bankowski and Rock, 1995;
Fonteneau et al., 2003). However, the identiﬁcation of Brefeldin
A-independent antigen cross-presentation (Pfeifer et al., 1993;
Belizaire and Unanue, 2009) and the discovery that components
for peptide loading are present in phagosomes (Houde et al., 2003;
Ackerman et al., 2005) suggest that peptide loading onto class I
MHC may occur also outside of the ER. Class I MHC molecules
are distributed in endosomal compartments, as shown in human
melanomaepithelial cells (Mel JuSo cells) and lymphoblastoid cells
(B-LCLs;Grommeet al., 1999;Kleijmeer et al., 2001). In contrast to
endosomal class II MHC molecules, that can directly transit from
the Golgi system to the endosomal pathway via association with
the invariant chain chaperone, a major route for endosomal local-
ization of class I MHC involves internalization from the plasma
membrane. Peptide-class I MHC interactions are destabilized in
late endosomal compartments (pH around 5.0), thereby facilitat-
ing peptide loading (Gromme et al., 1999). Further support came
from TAP inhibition studies in which TAP function in the early
and recycling endosomal (transferrin-positive) compartment was
selectively disrupted (Burgdorf et al., 2008). Endosomal peptide
loading would contribute to rapid cross-presentation of a selective
set of endocytosed antigen-derived peptides, while decreasing the
risk for competition with endogenous peptides that are assembled
into peptide/class I MHC complexes in the ER.
For efﬁcient endosomal peptide/class I MHC loading, class
I MHC molecules must be delivered into the peptide loading
compartment. Class I MHC molecules are constitutively inter-
nalized (Vega and Strominger, 1989). Mutational analysis of the
cytoplasmic domain of class I MHC molecules identiﬁed several
key residues that are essential for internalization (Lizee et al.,
2003; Basha et al., 2008). An evolutionary-conserved tyrosine
residue mediates the delivery into lysosomes (Lizee et al., 2003).
This tyrosine residue is part of a known targeting motif YXX∅
(Y= tyrosine,X= any amino acid,∅= bulky hydrophobic amino
acid) that has been shown to bind directly to adaptor protein (AP)-
1, 2, or 3 (Bonifacino and Dell’Angelica, 1999). AP-tyrosine motif
interaction results in selective incorporation of motif-containing
cargo, such as the transferrin receptor, in clathrin-coated vesi-
cles for uptake (Lizee et al., 2005). Besides endosomal targeting
mediated by the tyrosine-based motif, the cytoplasmic domain
of class I MHC molecules contains two or three conserved lysine
residues (Duncan et al., 2006). Lysines are targets for ubiquitina-
tion that can also induce clathrin-mediated endocytosis. Studies
on immune evasion strategies employed by Kaposi sarcoma asso-
ciated herpesvirus (KSHV) identiﬁed two viral proteins, K3 and
K5, that can downregulate cell surface bound class I MHC mole-
cules via poly-ubiquitination (Lorenzo et al., 2002). Two human
homologous proteins of K3 and K5, the membrane-associated
RING-CH family MARCH IV and IX, are key regulators in class II
MHC surface expression in B cells andDC (Gassart de et al., 2008).
Moreover,MARCH IV and IX ubiquitinate class IMHCmolecules
and induce its internalization in an overexpression system (Bar-
tee et al., 2004). Possibly these proteins can facilitate class I MHC
endocytosis under physiological conditions, but this remains to
be established. Thus, class I MHC molecules are taken up into
the endosomal pathway of DC in a clathrin-dependent manner,
enabling for sufﬁcient amounts of endosomal class I MHC mole-
cules to assemble into antigenic peptide/class I MHC complexes.
As T cell activation requires presentation of multiple antigen-
speciﬁc peptide/class I MHC complexes, the efﬁcient transport
of peptide/class I MHC complexes from peptide loading compart-
ment to the cell surface is a further cross-presentation requirement
that needs to be attained.
RECYCLING OF ENDOSOMAL CLASS I MHC
The intracellular location where peptide/class I MHC complexes
are assembled dictates the trafﬁcking route that is taken. Pep-
tide loading within the ER probably results in transport via the
biosynthetic pathway to the cell surface. In contrast, endosomal
peptide/class I MHC assembly suggests an alternative route of
transport.
The endosomal pathway contains both vesicular and tubu-
lar structures (Kleijmeer et al., 2001; Boes et al., 2002). During
endocytosis, cell surface-derived membrane proteins and lipids
are concomitantly taken up with antigen into endosomal vesicles
(Scita and Di Fiore, 2010). To ensure steady surface display, most
of the proteins and lipids are rapidly returned to the plasmamem-
brane via the endosomal recycling pathway that consists of two
main routes. Within minutes, retrograde recycling of membrane
proteins from the EE to plasma membrane may occur, whereas a
slower recycling route exists via juxtanuclear endosomal recycling
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compartments (ERC; Sonnichsen et al., 2000). It was estimated
that cells internalize the equivalent of their cell surface one to
ﬁve times per hour (Steinman et al., 1983), demonstrating the
importance of endosomal recycling to normal cellular function.
There is experimental support that the recycling pathway
may play a considerable role in antigen cross-presentation.
Pharmacological inhibition of the recycling pathway by inclu-
sion of primaquine in murine DC cultures abrogates cross-
presentation of exogenous soluble antigen, without affecting class
I MHC-mediated presentation of endogenously expressed anti-
gen (Burgdorf et al., 2008). Similarly, Di Pucchio et al. (2008)
report cross-presentation of a viral antigen by plasmacytoid DC in
aBrefeldinA-resistant,but primaquine-sensitivemanner. Further-
more, silencing of the small GTPases Rab3b and 3c, that colocalize
with class I MHC molecules in recycling endosomes (RE) of
DC2.4 cells, inhibits cross-presentation (Zou et al., 2009). Finally,
mouse DC lacking class I MHC in recycling compartments due to
expression of class I MHC with an aberrant tyrosine-based motif,
are defective in cross-presentation (Lizee et al., 2003). Together,
these reports demonstrate that interfering with the recycling path-
way of class I MHC can abrogate cross-presentation, but the exact
DC-intrinsic mechanisms for class I MHCmolecule recycling that
are involved in cross-presentation remain elusive.
The endosomal targeting of internalized antigen involves the
selective recruitment of signaling molecules [i.e., EHD1 (Jovic
et al., 2009) and Rab effector molecules (Hayakawa et al., 2007)].
One factor that regulate selective recruitment of signaling mol-
ecules is the small GTPase Arf6 (Brown et al., 2001). GDP/GTP
cycling affects Arf6 function in membrane lipid and protein recy-
cling. Active GTP-bound Arf6 localizes to the cytosolic side of the
plasma membrane for clathrin-independent endocytosis, whereas
GDP-bound Arf6 localized to tubular-like endosomal structures
(Caplan et al., 2002).
The Rab family of small GTPases are considered key regula-
tors of endocytic trafﬁcking (Stenmark, 2009; Figure 1). Rab22a
colocalizes with class I MHC in Arf6-associated tubules (Weigert
FIGURE 1 | Molecular mechanisms coordinating cargo recycling in the
endosomal compartment. Antigens can be internalized by phagocytosis
and (receptor-mediated) endocytosis and converge into early endosomes
(EE). Class I MHC molecules are taken up by either clathrin-mediated
endocytosis dependent on tyrosine-based internalization motif or
poly-ubiquitination, or clathrin-independent but GTP-bound Arf6-dependent
mechanism. The small GTPase Rab proteins dictate the selection of
different effectors and binding partners, thereby directing cargo to distinct
endosomal compartments, involving late endosomes (LE), lysosomes (lys),
recycling endosomes (RE), and the endosomal recycling compartment
(ERC). Rab3b and 3c are involved in rapid recycling of transferrin and are
involved in cross-presentation. Rab4 together with Rab11 and Sorting
Nexin 4 (SNX4) sort cargo into the ERC. Rab22a regulates class I MHC
recycling via Arf6-positive tubules. Rab35 mediates recruitment of EHD1
for class I MHC recycling from early endosomes. EHD1 also colocalizes
with Rab11 and its Rab11-FIP2, Arf6, and the Rab4 and Rab5 effector
Rabenosyn-5. During Rab5-to-Rab7 transition, the retromer complex
directs cargo to the trans-Golgi Network (TGN). The increased blue
coloration illustrates the drop in endosomal pH. Further information and
references are mentioned in the main text. =Class I MHC molecules;
=peptide; =Clathrin; =Rab; =GTP-bound Arf6; =GDP-bound
Arf6.
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et al., 2004), and the expression of dominant active or inactive
versions of the Rab22a protein, or depletion of Rab22a, impairs
class I MHC recycling to the cell surface (Weigert et al., 2004).
Also other members of the Rab family are pivotal to class I MHC
recycling. Both Rab35 (Allaire et al., 2010) and Rab11 (Sheff et al.,
1999) are implicated in recycling from the ERC to the cell sur-
face. Rab11 in complex with its effector Rab11-FIP2 interacts with
one of four knownmammalian C-terminal Eps15 homology (EH)
domain containing proteins (EHD1;Naslavsky et al., 2006) that all
play a role in endosomal trafﬁcking (Naslavsky and Caplan, 2011).
EHD1 is essential for recycling of both clathrin-dependent and
independent endocytosed molecules, including but not restricted
to class I MHC (Caplan et al., 2002) and class II MHC (Walseng
et al., 2008).
Next to the recycling pathway via the juxtanuclear ERC, class I
MHCmoleculesmay also be directed toward the TGN for entering
the biosynthetic pathway. Retrograde transport from the endo-
somal compartment to the TGN involves a hetero-pentameric
complex called the retromer (reviewed in Bonifacino and Hurley,
2008). Thus far, however, interaction between class I MHC mole-
cules and retromer complexes is not reported. However, depletion
of the retromer-distinct sorting nexin SNX4 results in disrup-
tion of the ERC, and miss-sorting of the transferrin receptor
to lysosomes. Therefore, SNX4 appears important for shuttling
selective cargo between EE and the ERC (Traer et al., 2007). In
conclusion, the ERC is a highly dynamic compartment composed
of vesicular and tubular membrane structures, in which proper
interplay between molecules including GTPases and Rab proteins
contributes to antigen cross-presentation.
DIRECTED MIGRATION ENABLED BY ASSOCIATION OF
ENDOSOMAL COMPARTMENTS WITH CYTOSKELETAL
ELEMENTS
Membrane-associated cargo, including class I MHC molecules,
is selectively transported to distinct endosomal compartments.
But what regulates the structural support necessary for endosomal
trafﬁcking?
All eukaryotic cells have a ﬁlamentous network of cellular
proteins, collectively termed the cytoskeleton. It mainly com-
prises three distinct classes of ﬁbers:microﬁlaments,microtubules,
and intermediate ﬁlaments. The cytoskeleton has multiple tasks.
It gives the cell its rigidity and strength that helps maintain-
ing cell shape. Moreover, it provides tracks that allow directed
movement of organelles and their transport intermediates during
intracellular trafﬁcking processes. Microtubules are major com-
ponents of the cytoskeleton, and are composed of α and β tubulin
heterodimers. Disruption of these microtubules perturbs Arf6-
associated recycling tubules (Radhakrishna andDonaldson, 1997),
and thereby may abrogate endosomal transport of peptide/class I
MHC complexes.
The continuous assembly and disassembly of microtubules
creates a temporal and spatial dynamic network that allows for
long-range endosomal transport (Jiang and Akhmanova, 2011).
This network allows directional movements of motor proteins
that associate with these microtubule tracks. Kinesins and dyneins
are two families of such motor proteins. Most kinesins migrate
over the microtubules in plus-end direction toward the cell
periphery, whereas dyneins are directed to the minus-end, toward
themicrotubule-organizing center (MTOC;Wubbolts et al., 1999).
Various cargo-selecting molecules or complexes from the endoso-
mal compartment are linked to the motor proteins, allowing sep-
aration and movement of endosomal vacuoles over these micro-
tubule tracks. For instance, several Rab proteins are associated
directly tomotor proteins, such as Rab14 with kinesin (Ueno et al.,
2011) and Rab4 with dynein (Bielli et al., 2001). Similar to SNX4,
most Rab proteins are indirectly linked to motor proteins via
adaptor proteins, allowing separate trafﬁcking processes in distinct
responses. For example, Rab6 can interact with Bicaudal-related
protein 1 (BICDR-1) or Bicaudal D-2 to associate with kinesin-
3 or 1 respectively (Grigoriev et al., 2007; Schlager et al., 2010).
Thus, endosomal small GTPase activity of Rab proteins can affect
motor–microtubule interaction, thereby altering the segregation
or guidance of cargo transport.
Directed assembly of microtubules may also allow for polar-
ized trafﬁcking and delivery of membrane proteins or (soluble
mediator) cargo in high concentration to one speciﬁc spot. Upon
cognate interaction between an antigen presenting cell (APC)
and a T cell, the cytoskeleton forms a highly organized struc-
ture called the immunological synapse (IS). The IS is a region of
spatially and temporally organized, highly concentrated motifs of
membrane proteins and cytosolic molecules, formed at the T cell
interaction site. The formation of the IS in DC is critical for subse-
quent T cell activation and depends on cytoskeletal rearrangement
(Pulecio et al., 2008). Perturbation of the cytoskeleton abrogates
IS formation and subsequent T cell activation (Al-Alwan et al.,
2001). Endosomal compartments that transport class II MHC
molecules converge at the IS upon cognate DC-T cell interac-
tion (Boes et al., 2002, 2003; Bertho et al., 2003). In addition, a
recent study demonstrates that ICAM-1, an adhesion molecule
involved in strengthening the DC-T cell interaction, is targeted
to the IS. This occurs either via the cell surface by cytoskeleton-
dependent active transport, or via RE, where it colocalizes with
class II MHC molecules. The latter pathway depends on contin-
uous endocytosis and recycling of ICAM-1. Polarization of the
recycling ICAM-1 to the DC-T cell interaction site in its turn
depends on the high-afﬁnity state of the ICAM-1 binding partner
LFA-1 on T cells (Jo et al., 2010). This was not unexpected, as it was
described earlier that blocking LFA-1with an antibody on antigen-
speciﬁc CD4+ T cells hampers remodeling of the endosomal class
II MHC-containing compartment in murine DC (Bertho et al.,
2003). Taken together, these data demonstrate that T cell-directed,
cytoskeleton-supported recycling of antigen cargo is crucial for
cellular immune responses.
In all cell types mentioned, the small GTPase CDC42 of the
Rho family was shown to be responsible for MTOC polarization
(Eng et al., 2007; Pulecio et al., 2010; Yuseff et al., 2011). Specif-
ically, Pulecio et al. (2010) show that CDC42-mediated polariza-
tion mediates both MTOC polarization and directed transport
of the cytokine IL-12 to the DC-T cell interaction site, which
was crucial for antigen-speciﬁc CD8+ T cell proliferation and
IFNγ production. Yuseff et al. (2011) demonstrated that atypi-
cal PKC is a downstream target of CDC42, required for MTOC
polarization. CDC42 may be responsible for MTOC relocation
by a mechanism that recruits the PAR6-atypical PKC complex
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to the plasma membrane in an Arf6-dependent manner, as was
demonstrated to facilitate the establishment of polarity in migrat-
ing astrocytes (Etienne-Manneville and Hall, 2001; Osmani et al.,
2010). Moreover, PAR6 overexpression reduced MTOC reorien-
tation in murine macrophages (Eng et al., 2007). Taken these
data together, CDC42-based polarity machinery plays an instru-
mental role in the polarization of the microtubule network and
inﬂuences the direction of RE and other microtubule-associated
trafﬁcking.
IMPLICATIONS TO HUMAN INFECTIOUS DISEASES
Abrogated transport or recycling of class I and class II MHC com-
plexes leads to immune-related disorders, as might be expected
considering their importance in the initiation of immune- or
tolerogenic responses. Indeed, an inefﬁcient MHC transport leads
to severe combined immunodeﬁciency as in patients with Bare
Lymphocyte Syndrome type I. This disease can be caused by
mutation in the TAP1, TAP2, or TAPBP genes, all leading to inef-
ﬁcient peptide/class I MHC transport and ultimately decreased
cell surface expression (Salle de la et al., 1994). Hampering the
transport of peptide/MHC complexes also plays a major role
in viral infections. Herpes and Pox viruses can evade immune
responses. They do this by several mechanisms including pre-
venting the presentation of newly synthesized class I MHC mol-
ecules at the cell surface by blocking peptide translocation via
TAP, block of peptide loading, retention of MHC/peptide com-
plexes in the ER or their retrograde translocation into the cytosol
for degradation, as illustrated in Figure 2 (van der Wal et al.,
2002; Hansen and Bouvier, 2009; Horst et al., 2011). Increased
MHC internalization also limits plasmamembrane displayed pep-
tide/class I MHC complexes and subsequent T cell activation
(Zuo et al., 2011). Thus far no inborn mutations are known
that correlate with mechanisms of MHC recycling or degrada-
tion. However, pathogens developed immune evasion strategies
that interfere with endosomal transport of MHC or its recycling
from the plasma membrane, with possible implications to antigen
cross-presentation.
For example, EBV-derived BILF-1 and the previously men-
tioned K3 and K5 of KSHV decrease class I MHC surface expres-
sion by increasing its internalization, aiding the virus in escaping
the immune system (Coscoy and Ganem, 2000; Ishido et al.,
2000; Lorenzo et al., 2002; Mansouri et al., 2006; Zuo et al.,
2011). HIV uses multiple strategies to evade the immune sys-
tem (Roeth et al., 2004; Dikeakos et al., 2010). HIV-1 expresses
FIGURE 2 |Viral evasion strategies aim at different pathways of MHC
transport. 1: Inhibition of proteasomal processing (EBV); 2: Inhibition of TAP
(EBV, HSV, CMV); 3: Inhibition of peptide transport (EBV, CMV, adeno); 4:
Retaining MHC molecules in the ER (adeno, cowpox); 5: Target MHC for
proteasomal degradation (CMV); 6: Target MHC fromTGN to endo/lysosomal
compartments (HIV); 7: Clathrin-dependent MHC internalization (EBV, KSHV,
HIV, CMV); 8: Clathrin independent MHC internalization (HIV); 9: Arresting
phagosomal maturation (mycobacteria, Salmonella, Chlamydia, and
Leishmania); 10: Targeting MHC to the LE/lysosome (HSV); 11: Inhibition of
retromer activity (HVS); 12: Inhibition of progression to the RE (CMV, HSV).
=protein; =peptide; =TAP; =Clathrin; =Class I MHC molecules;
=proteasome; =GTP-bound ARF6.
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the Nef protein that targets newly synthesized class I MHC from
the TGN to the destructive lysosomal compartments, thereby pre-
venting cell surface expression of peptide/class I MHC. Moreover,
Nef increases the turnover of MHC surface molecules by targeting
MHC to lysosomes via the clathrin-dependent retromer-mediated
pathway (Peterlin and Trono, 2003). Additionally, Nef and host-
derived sorting protein PACS1 interfere with MHC recycling by
targeting and retaining MHC from the plasma membrane in the
TGN via the previously described clathrin-independent ARF6
endocytic pathway (Blagoveshchenskaya et al., 2002). Recycling
of MHC is also abrogated by Murine Cytomegalovirus, which
induces an arrest of MHC in EE (Tomas et al., 2010). The retromer
is also targeted for immune evasion as was reported for Her-
pesvirus Saimiri (HVS) infection. HVS-derived tyrosine kinase-
interacting protein binds and redistributes the retromer subunit
Vps35 from the EE to lysosomes, thereby inhibiting retromer
activity. This is physiologically linked to CD4+ T cell downreg-
ulation and immortalization (Kingston et al., 2011), but possible
retromer-targeted effects by HVS on cross-presentation remain to
be shown.
The enormous number of viruses targeting peptide/MHC
expression and endosomal trafﬁcking illustrates its crucial role
in anti-viral responses. Bacteria can also use these mechanisms
to create an environment in which they can thrive (Duclos and
Desjardins, 2000). Intracellular pathogens can replicate in vac-
uoles that retain an elevated pH, show limited hydrolytic activ-
ity, and intersect poorly with antigen presentation pathways. To
achieve this, pathogens such asMycobacteria hamper phagosome–
lysosome fusion and Salmonella delays vacuolar acidiﬁcation,
thereby inducing arrest of phagosomal maturation (Jantsch et al.,
2011; Johansen et al., 2011). Bacteria can also use endosomal
remodeling and recycling for their own beneﬁt. For example,
Rab14 and syntaxin 6, which are together with IRAP involved
in cross-presentation (Saveanu et al., 2009; Weimershaus et al.,
2012), are recruited to Chlamydial inclusion vacuoles (Capmany
et al., 2011;Moore et al., 2011).Also, a recent investigation demon-
strates that Salmonella induces kinesin activity by the expression
of Arl8B, an Arf family member (Kaniuk et al., 2011). Concomi-
tant with increased kinesin activity, endosomal remodeling into
tubular-like structures is promoted by Arl8B (Kaniuk et al., 2011),
thereby creating an opportunity for Salmonella to transfer from
cell to cell.
In summary, peptide/MHC surface expression is pivotal in
initiating T cell responses and is therefore an important target
in pathogen evasion strategies. Pathogens interfere with endo-
somal transport of MHC molecules to the plasma membrane,
internalization of MHC and subsequent recycling or degradation.
Knowledge of these processes is important in therapeutic interven-
tions aiming at clearance of infections via appropriately activated
MHC-restricted T cell responses. Drugs speciﬁcally targeting viral
evasion molecules could re-establish proper peptide/MHC pre-
sentation, thereby allowing the immune system to clear the virus.
Secondly, it is important to clarify evasion strategies employed by
prevalent pathogens in future cellular vaccination developments,
e.g., DC-based vaccine strategies, since such evasion could impair
vaccine effectiveness.
CONCLUDING REMARKS
Efﬁcient cross-presentation of CD8+ T cells that initiates bal-
anced anti-viral and anti-tumor immune responses depends on
DC-intrinsic mechanisms that enable the sequential interaction
of speciﬁc TCR molecules with peptide/MHC complexes in the
context of activating or inhibiting (tolerogenic) signals. The mol-
ecular mechanisms described in this review all aid to ensure the
quantity and quality of this DC-derived signal toward the CD8+
T cells.
Antigen recognition by speciﬁc receptors permits the selec-
tive and rapid retrieval of antigens present in the extracellular
ﬂuid, focusing the antigen pool that is directed toward cross-
presentation. Additionally, targeting antigen to speciﬁc receptors
allow it to target toward superior cross-presenting DC subsets
(Sancho et al., 2009), or to overcome prior incapability of anti-
gen cross-presentation (Klechevsky et al., 2010). Not surpris-
ingly, targeting antigen increases antigen cross-presentation in vivo
(National Library of Medicine US, 2010; Flynn et al., 2011) and
is currently used in ﬁrst phase clinical trials (140, DCVax-001). It
now appears that next to efﬁcient antigen uptake, receptor selec-
tion is instrumental for antigen delivery to cross-presentation
competent compartments. Antigen introduction, as well as co-
presence of “danger signals” appears to optimize, at least in some
circumstances, the capability of selective endosomal compart-
ments to support antigen cross-presentation, by recruitment of
necessary components for cross-presentation (Naslavsky et al.,
2006; Jancic et al., 2007; Burgdorf et al., 2008; Kim et al., 2008).
Dendritic cellsmaturation is accompanied by dramatic changes
in cell shape. Since the cytoskeleton is responsible for cell shape,
danger signaling is likely involved in cytoskeletal reorganiza-
tion. Indeed, Toll-like receptor 4 (TLR4) signaling induces actin
cytoskeleton remodeling in a MyD88-dependent manner (West
et al., 2004). In addition, MTOC reorientation in DC by binding
of antigen-speciﬁc T cells required TLR signaling (Pulecio et al.,
2010). However, this could be an indirect effect due to the fact
that mature DC form more stable synapses than immature DC
(Benvenuti et al., 2004). Moreover, innate signals via MyD88 are
demonstrated in murine DC to remodel the late endosomal com-
partment in which class II MHC peptide loading occurs (Boes
et al., 2002). All together, these data demonstrate a beneﬁcial role
for innate signaling in presentation of antigens. However, exact
molecular mechanisms that link innate signaling with directed
cargo transportation remain elusive.
A large amount of viral immune evasion strategies generated
by the evolutionary pressure of the endosomal recycling pathway
on anti-viral responses suggests that efﬁcient recycling of class I
MHC molecules is essential for an effective CD8+ T cell response.
An exon7-deleted variant of class IMHC clearly demonstrates that
only a small delay in class I MHC recycling greatly affects CD8+
T cell responses (Rodriguez-Cruz et al., 2011): antigen cross-
presentation by exon7-deleted class I MHC molecules-expressing
cells results in more robust CD8+ T cell responses.
The quality of the MHC/TCR interaction (e.g., signal 1)
affects DC-CD8+ T cell interaction strength, thereby affecting
CD8+ T effector function (Bouma et al., 2011), memory dif-
ferentiation (Teixeiro et al., 2009) and survival (Iezzi et al.,
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1999). Hence, primary immune deﬁciencies with defective quality
of signal 1, such as Wiskott-Aldrich syndrome and DOCK8
immunodeﬁciency patients, share clinical characteristics (e.g.,
eczema, elevated IgE levels, cutaneous M. contagiosum or Papil-
loma and Herpes viral infections, and increased tumor incidence
(Bosticardo et al., 2009; Zhang et al., 2009). Both Dock8 and
WAS protein are important for T cell synapse formation (Dupre
et al., 2002; Randall et al., 2011), and crucial for interactions
between naive CD8+ T cells and DC (Pulecio et al., 2008; Randall
et al., 2011). Thus, the endosomal recycling pathway may prove
of importance for antigen cross-presentation and prevention of
correlated diseases via distinct mechanisms, some of which are
outlined above, and likely with more to be uncovered in the years
to come.
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